Jefferies raises Molina Healthcare stock price target on 2027 rate data
Jefferies raised its price target for Molina Healthcare (NYSE:MOH) to $220 from $205, maintaining a Hold rating. The stock trades near $216.64, with InvestingPro valuing it at $271.91. Jefferies cited 2027 rate data, including a 7% average premium increase. Q3 results missed Medicaid expectations but met Medicare and Exchange targets. Molina's Q3 earnings and revenue beat estimates, but guidance remained unchanged. Cantor Fitzgerald reiterated a Neutral rating with a $209 target.
How this was made
The 30-second read
Why it matters
Analyst upgrade provides fresh data for traders; however, the Hold rating tempers immediate buying pressure.
Market read
The target raise adds modest upside potential for MOH, but limited broader market effect.
What to watch
Potential cost pressures from new Florida contract could offset rate‑increase benefits.
Background
Jefferies' price‑target adjustment follows Molina Healthcare's Q3 2026 earnings beat but unchanged full‑year guidance.
Ticker impact
Jefferies raised its price target on Molina Healthcare to $220 from $205, citing 2027 rate increase data.
likely upward pressure as investors price in higher target
The new target is above current price, but the rating remains Hold, limiting aggressive buying.
Market effects
May reinforce positive sentiment for the managed‑care sector if rate‑increase assumptions hold.
Limited to U.S. health‑care equities.
Low global impact.
Counterpoint
Target raise may be premature if 2027 enrollment assumptions prove optimistic.
Key entities
- companyMolina Healthcare
U.S. managed‑care insurer (ticker MOH).
- analyst_firmJefferies
Equity research firm issuing the target raise.
